StockData
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31

MEDIFAST INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$12.03+0.15 (+1.26%)

Close on Oct 19, 2026

Market cap
$133.95M
P/E (TTM)
–
Dividend yield
0.00%

MEDIFAST INC revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2017FY2016FY2015FY2014FY2013FY2012% of revenueYoY
Optavia Segment$385.79M$602.46M$1.07B$1.60B––––––100.0%-36.0%
Other––––––––$0$0––
Medifast Inc––––––––$304.25M$300.51M––
MWCC & Wholesale––––––––$52.64M$56.20M––
Medifast Direct [Member]––––$31.90M$35.14M$48.66M$57.16M$75.52M$84.42M––
Take Shape For Life [Member]–––––$222.40M$202.22M$206.66M$228.73M$216.09M––
MWCC [Member]––––$12.19M$15.67M$17.07M$15.42M$15.34M$14.31M––
Medifast Wholesale [Member]––––$931.00K$1.32M$4.83M$6.05M$4.47M$3.75M––
Optavia [Member]––––$256.54M$222.40M$202.22M–––––

By product or service

By region

From the segment and revenue-disaggregation notes of Medifast's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.